Adult Acute Lymphoblastic Leukemia — Trials

Adult Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

249 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 44
Recruiting: 21
Ph III recruiting: 1
Growth YoY: —
Industry share: 7%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (37)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07313852	A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia	not yet recruiting	Phase 1 / Phase 2	26	Memorial Sloan Kettering Cancer CenterOTHER	1	Aug 11, 2026	clinicaltrials
NCT07412405	This Clinical Trial is a Single-arm, Non-randomized Pilot Trial to Determine the Safety of Administering Autologous Anti-C19 Cells (ARI-0001) and the Feasibility of Local CAR-T Cell Production in Patients Over 18 Years of Age With Relapsed/Refractory (R/R) CD19+ Hematologic Malignancies, Including R(ACITAC-001)	not yet recruiting	N/A	12	GUSTAVO SALGUERO